Lilly Together™ 14.0.0

Lilly Together™ is a mobile application designed to assist users of Taltz® (ixekizumab), Olumiant® (baricitinib), or Omvoh™ (mirikizumab-mrkz) in monitoring their treatment progress. For detailed information on the indications, safety summary, and warnings for Olumiant® (baricitinib), please refer to the official website at Olumiant Safety Summary.

Key features of the Lilly Together™ mobile app include:

• Plan Setup: Customize your dosing plan, set reminders, and keep track of your medication schedule.
• Treatment Map: Get an overview of your treatment journey for the initial 6 months, including touchpoints, dosing guidelines, and symptom monitoring.
• Dose/Medication Tracking: Record your injections to ensure adherence to your Healthcare Provider's instructions.
• Symptom Tracking: Monitor your symptoms over time and store related photos securely within the app.
• Progress Tracking: Take charge of tracking your progress to aid in productive discussions with your Healthcare Provider.
• Logbook Report: Generate a comprehensive report displaying a 90-day snapshot of your symptom and dosing trends for insightful discussions with your Healthcare Provider.

In addition, the app offers various features such as Savings Card enrollment, Sharps Disposal container requests, access to useful resources, and customer support for eligible users. Please note that Lilly Together™ is exclusively available for use by U.S. residents aged 18 and above. It is not a substitute for professional medical advice or decision-making by licensed Healthcare Providers.

For further assistance or inquiries, feel free to contact 1-844-486-8546. Lilly Together™ and the associated trademarks are owned or licensed by Eli Lilly and Company and its affiliates.

Trademarks: Taltz® and its delivery device base are trademarks of Eli Lilly and Company or its affiliates. Olumiant® is a registered trademark of Eli Lilly and Company or its affiliates. Omvoh™ and its delivery device base are trademarks of Eli Lilly and Company or its affiliates.

[PP-LU-US-0732]